EHA Stockholm 2018
Congratulations to the winning entrants of the UKMF travel bursary to ASH in Atlanta in December 2017. Each award will be to the value of £1000.
We have teamed up with our Platinum Sponsors to award a joint UKMF travel bursary.
Takeda – Christopher Marlein, University of East Anglia
Amgen – Karen Menezes, Institute of Cancer Research
Binding Site – Faouzi Djebbari, Churchill Hospital, Oxford
Celgene – Lisa Crawford, Queens University, Belfast
Winners
-
2018-12-01 — ASH 2018 – San Diego[ + ]
-
ASH 2012 Atlanta Winning abstracts[ + ]
- Clinical Drug Resistance Linked to Inter-Convertible Phenotypic and Functional States of Tumor-Propagating Cells in Multiple Myeloma
- Intra-Clonal Heterogeneity Is a Critical Early Event in the Preclinical Stages of Multiple Myeloma and Is Subject to Darwinian Fluctuation throughout the Disease
- The Impact of Thalidomide Maintenance Therapy Varies Dependent Upon Biological Risk Grouping
-
IMW Travel Grant Winners 2013 Kyoto[ + ]
Congratulations to Christopher Parrish and Sarah Essex, who have been awarded travel grants to attend the IMW in Kyoto in April 2013. Their winning abstracts can be found here.
-
ASH 2013 New Orleans[ + ]
Thank you to all those who applied for the 2013 UKMF travel bursaries to ASH. Four abstracts were selected and this year the standard was incredibly high. The abstracts are here.
Both Brian Walker and Martin Kaiser submitted two abstracts (oral and poster).
- Exome sequencing to define a genetic signature of plasma cells in systemic AL amyloidosis
- MYC Translocations in Multiple Myeloma Involve Recruitment of Enhancer Elements Resulting in Over-Expression and Decreased Overall Survival
- Discovery of genome wide epigenetic programming in t(4;14) multiple myeloma and in the progression from myeloma to plasma cell leukemia via methyl binding domain protein capture and sequencing
- A rapid and robust molecular diagnostic approach for multiple myeloma – results from a large trial cohort
- Designing APRIL-Based Therapeutics for Targeting BCMA in Multiple Myeloma
- Use of plasma cell immunophenotype as prognostic markers in patients with systemic AL amyloidosis.
-
IMW Rome Winning Abstracts[ + ]
Congratulations to the following well deserved winners of the UKMF Travel Bursary to Rome. In total 6 bursaries were awarded. One of the travel bursaries was sponsored by Takeda, of which we are very grateful.
Nicola Maciocia
Lisa Crawford
John Jones
Shameem Mahmood
Charlotte Attwood
Ieuan Walker
- Aim: To assess the real-world clinical efficacy of POMA-DEX in several large UK centres.
- HUWE1 is a potential therapeutic target in Multiple Myeloma
- Guidelines for the correct determination of second primary malignancies in myeloma trials
- Bleeding Diathesis and prothrombotic tendencies in newly diagnosed systemic light chain Amyloidosis patients: important clinical implications in management
- Melphalan 140mg/m2 significantly reduces 5 year progression free survival in multiple myeloma patients receiving a peripheral blood autologous stem cell transplant compared with melphalan 200mg/m2.
- A single centre retrospective analysis of diagnostic fluorescence in situ hybridisation reveals distinct groups of cytogenetic abnormalities, which affect early survival of new myeloma diagnosis
-
EHA Stockholm 2018[ + ]
We are delighted to announce the following winners who will receive £700 to cover the registration cost of attending the EHA conference in Stockholm in June 2018.
We are grateful to our Platinum sponsors The Binding Site, Takeda, Celgene and Amgen for supporting these bursaries.
Michael Austin – ST3 Trainee in Haematology at the Royal Marsden
Polly Talley – Clinical Scientist at St James’s Hospital in Leeds
Priya Sriskandarajah – Clinical Research Fellow at the ICR
Lisa Hammond – Myeloma and Transplant nurse specialist at the Royal Bournemouth Hospital.
Well done and congratulations to our worthy winners!